FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030677639> ?p ?o ?g. }

• W2030677639 endingPage "161" @default.
• W2030677639 startingPage "156" @default.
• W2030677639 abstract "We have proposed that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) of Leydig cells protects against glucocorticoid-induced inhibition of testosterone (T) production. However, Leydig cells express type I 11 beta-HSD, which has been shown to be reductive in liver parenchymal cells. Because reduction would have the opposite effect of activating glucocorticoid, the present study was designed to determine: 1) whether Leydig cell 11 beta-HSD is primarily oxidative or reductive; and 2) whether oxidative and reductive activities are separately modified by known regulators of Leydig cell steroidogenic function. Leydig cells and liver parenchymal cells were purified from mature male Sprague-Dawley rats (250 g BW), and 11 beta-HSD oxidative and reductive activities were measured using radiolabeled substrates and TLC of triplicate media samples from 1-h incubations immediately after cell isolation. Enzyme activities also were examined in purified Leydig cells at the end of 3 days of culture in vitro in the presence of LH (10 ng/ml), dexamethasone (DEX, 100 nM), T (50 nM), or epidermal growth factor (EGF, 50 ng/ml). In confirmation of previous reports, the reductive activity of 11 beta-HSD was predominant over oxidation in liver parenchymal cells. In contrast, 11 beta-HSD oxidative activity prevailed over reduction in Leydig cells by a ratio of 2:1. The activities of 11 beta-HSD also were analyzed in Leydig cells that were purified 7 days after endogenous glucocorticoid levels were suppressed by adrenalectomy (ADX). Oxidative activity declined in Leydig cells after ADX (22.53 +/- 1.12 pmol/h.10(6) cells, mean +/- SEM vs. 31.47 +/- 1.48 pmol/.10(6) cells in sham-operated controls, P < 0.05), whereas there was no change in reductive activity. This indicated that physiologically active corticosterone is involved in maintaining the predominance of 11 beta-HSD oxidation. When enzyme activities were analyzed in Leydig cells after 3 days of hormonal treatment in vitro, oxidation and reduction were observed to change in opposing directions. Culture of Leydig cells from sham-operated control rats with either LH, T, or EGF resulted in declines in oxidative activity from 33.35 +/- 0.77 to 28.24 +/- 1.93, 27.30 +/- 0.96, and 24.13 +/- 1.02 pmol/ h.10(6) cells (x +/- SE), respectively. However, EGF stimulated 11 beta-HSD reductive activity in cultured Leydig cells from both control (from 18.97 +/- 1.10 to 27.16 +/- 0.71 pmol/h.10(6) cells and ADX rats (from 16.51 +/- 0.75 to 23.56 +/- 0.84 pmol/h.10(6) cells). Among the hormonal treatments, only DEX increased oxidative activity and simultaneously decreased reductive activity in Leydig cells from ADX rats. This increase accentuated the predominance of oxidative activity in Leydig cells, with a ratio of oxidative to reductive activity of 4:1 after DEX treatment, compared with 2:1 in controls that were untreated. We conclude that 11 beta-HSD activity in Leydig cells is primarily oxidative. Moreover, oxidation and reduction are regulated separately by hormones." @default.
• W2030677639 created "2016-06-24" @default.
• W2030677639 creator A5049155080 @default.
• W2030677639 creator A5062081159 @default.
• W2030677639 creator A5065408376 @default.
• W2030677639 creator A5088943958 @default.
• W2030677639 creator A5091243949 @default.
• W2030677639 date "1997-01-01" @default.
• W2030677639 modified "2023-10-02" @default.
• W2030677639 title "Hormonal Regulation of Oxidative and Reductive Activities of 11β-Hydroxysteroid Dehydrogenase in Rat Leydig Cells¹" @default.
• W2030677639 cites W1264829970 @default.
• W2030677639 cites W1503719518 @default.
• W2030677639 cites W1519525780 @default.
• W2030677639 cites W1964332980 @default.
• W2030677639 cites W1969255727 @default.
• W2030677639 cites W1971512885 @default.
• W2030677639 cites W1978280540 @default.
• W2030677639 cites W1994533492 @default.
• W2030677639 cites W1999635912 @default.
• W2030677639 cites W1999976336 @default.
• W2030677639 cites W2009703358 @default.
• W2030677639 cites W2010584142 @default.
• W2030677639 cites W2013220267 @default.
• W2030677639 cites W2024080996 @default.
• W2030677639 cites W2029499183 @default.
• W2030677639 cites W2033124168 @default.
• W2030677639 cites W2040851277 @default.
• W2030677639 cites W2040877330 @default.
• W2030677639 cites W2041995882 @default.
• W2030677639 cites W2043877630 @default.
• W2030677639 cites W2046375748 @default.
• W2030677639 cites W2064895901 @default.
• W2030677639 cites W2074595309 @default.
• W2030677639 cites W2090576262 @default.
• W2030677639 cites W2096833993 @default.
• W2030677639 cites W2123215155 @default.
• W2030677639 cites W2126072003 @default.
• W2030677639 cites W2136033439 @default.
• W2030677639 cites W2142464121 @default.
• W2030677639 cites W2148328115 @default.
• W2030677639 cites W2169174017 @default.
• W2030677639 cites W2499363915 @default.
• W2030677639 cites W63938293 @default.
• W2030677639 doi "https://doi.org/10.1210/endo.138.1.4837" @default.
• W2030677639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8977399" @default.
• W2030677639 hasPublicationYear "1997" @default.
• W2030677639 type Work @default.
• W2030677639 sameAs 2030677639 @default.
• W2030677639 citedByCount "56" @default.
• W2030677639 countsByYear W20306776392012 @default.
• W2030677639 countsByYear W20306776392013 @default.
• W2030677639 countsByYear W20306776392014 @default.
• W2030677639 countsByYear W20306776392016 @default.
• W2030677639 countsByYear W20306776392017 @default.
• W2030677639 countsByYear W20306776392019 @default.
• W2030677639 countsByYear W20306776392020 @default.
• W2030677639 crossrefType "journal-article" @default.
• W2030677639 hasAuthorship W2030677639A5049155080 @default.
• W2030677639 hasAuthorship W2030677639A5062081159 @default.
• W2030677639 hasAuthorship W2030677639A5065408376 @default.
• W2030677639 hasAuthorship W2030677639A5088943958 @default.
• W2030677639 hasAuthorship W2030677639A5091243949 @default.
• W2030677639 hasBestOaLocation W20306776391 @default.
• W2030677639 hasConcept C126322002 @default.
• W2030677639 hasConcept C134018914 @default.
• W2030677639 hasConcept C181199279 @default.
• W2030677639 hasConcept C185592680 @default.
• W2030677639 hasConcept C202751555 @default.
• W2030677639 hasConcept C2776151105 @default.
• W2030677639 hasConcept C2776317432 @default.
• W2030677639 hasConcept C2777736315 @default.
• W2030677639 hasConcept C2778575703 @default.
• W2030677639 hasConcept C2779279991 @default.
• W2030677639 hasConcept C2780841215 @default.
• W2030677639 hasConcept C54355233 @default.
• W2030677639 hasConcept C55493867 @default.
• W2030677639 hasConcept C57600042 @default.
• W2030677639 hasConcept C71315377 @default.
• W2030677639 hasConcept C71924100 @default.
• W2030677639 hasConcept C81885089 @default.
• W2030677639 hasConcept C86803240 @default.
• W2030677639 hasConceptScore W2030677639C126322002 @default.
• W2030677639 hasConceptScore W2030677639C134018914 @default.
• W2030677639 hasConceptScore W2030677639C181199279 @default.
• W2030677639 hasConceptScore W2030677639C185592680 @default.
• W2030677639 hasConceptScore W2030677639C202751555 @default.
• W2030677639 hasConceptScore W2030677639C2776151105 @default.
• W2030677639 hasConceptScore W2030677639C2776317432 @default.
• W2030677639 hasConceptScore W2030677639C2777736315 @default.
• W2030677639 hasConceptScore W2030677639C2778575703 @default.
• W2030677639 hasConceptScore W2030677639C2779279991 @default.
• W2030677639 hasConceptScore W2030677639C2780841215 @default.
• W2030677639 hasConceptScore W2030677639C54355233 @default.
• W2030677639 hasConceptScore W2030677639C55493867 @default.
• W2030677639 hasConceptScore W2030677639C57600042 @default.
• W2030677639 hasConceptScore W2030677639C71315377 @default.
• W2030677639 hasConceptScore W2030677639C71924100 @default.
• W2030677639 hasConceptScore W2030677639C81885089 @default.

• next